amlodipine has been researched along with Bleeding in 4 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| " hypertension clinical trial databases for amlodipine (Norvasc) and nifedipine in the gastrointestinal therapeutic system (GITS) formulation (Procardia XL)." | 4.80 | Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients. ( Kloner, RA; Levenstein, M; Materson, BJ; Vetrovec, GW, 1998) |
| " Since telmisartan is an inhibitor of P-glycoprotein (P-gp), the elimination of rivaroxaban and apixaban, which are substrates of P-gp, is hindered, resulting in increased blood levels of both drugs, thereby increasing the risk of hemorrhage." | 4.02 | Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users. ( Akagi, Y; Aoyama, T; Enomoto, A; Hoshiko, M; Kawano, Y; Kujirai, A; Mano, Y; Nagata, M; Nakamatsu, S; Nakamura, S; Negishi, K; Nishikawa, T; Shimada, S; Suzuki, T; Tsukada, E, 2021) |
| "To present cases in whom purpura or internal bleeding due to calcium-channel blockers was a presenting feature, including one subject with drug-induced haematuria and haematospermia due to amlodipine and one with the Rumpel-Leede sign." | 3.75 | Purpura and bleeding due to calcium-channel blockers: an underestimated problem? Case reports and a pilot study. ( Cox, NH; Robson, RH; Walsh, ML, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawano, Y | 1 |
| Nagata, M | 1 |
| Nakamura, S | 1 |
| Akagi, Y | 1 |
| Suzuki, T | 1 |
| Tsukada, E | 1 |
| Hoshiko, M | 1 |
| Kujirai, A | 1 |
| Nakamatsu, S | 1 |
| Nishikawa, T | 1 |
| Enomoto, A | 1 |
| Negishi, K | 1 |
| Shimada, S | 1 |
| Aoyama, T | 1 |
| Mano, Y | 1 |
| Cox, NH | 1 |
| Walsh, ML | 1 |
| Robson, RH | 1 |
| White, WB | 1 |
| Parke, AL | 1 |
| Kloner, RA | 1 |
| Vetrovec, GW | 1 |
| Materson, BJ | 1 |
| Levenstein, M | 1 |
1 review available for amlodipine and Bleeding
| Article | Year |
|---|---|
Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Topics: Amlodipine; Calcium Channel Blockers; Cause of Death; Cerebrovascular Disorders; Clinical Trials as | 1998 |
3 other studies available for amlodipine and Bleeding
| Article | Year |
|---|---|
Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users.
Topics: Administration, Oral; Administrative Claims, Healthcare; Amlodipine; Anticoagulants; Antihypertensiv | 2021 |
Purpura and bleeding due to calcium-channel blockers: an underestimated problem? Case reports and a pilot study.
Topics: Aged; Aged, 80 and over; Amlodipine; Calcium Channel Blockers; Female; Hemorrhage; Humans; Male; Mid | 2009 |
Acute pain in the tip of the index finger.
Topics: Acute Disease; Amlodipine; Arterial Occlusive Diseases; Aspirin; Cyanosis; Diagnostic Errors; Female | 2005 |